Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 5548-5560

  Cuda, Carla M ^a   Misharin, Alexander V ^a   Gierut, Angelica K ^a   Saber, Rana ^a   Haines III, G Kenneth ^b   Hutcheson, Jack ^c   Hedrick, Stephen M ^d   Mohan, Chandra ^c   Budinger, G Scott ^a   Stehlik, Christian ^a   Perlman, Harris ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING SERINE THREONINE KINASE 1; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNE DISEASES; CASPASE 8; DENDRITIC CELLS; IMMUNE TOLERANCE; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84902127968     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400122     Document Type: Article

References (52)

1. Hutcheson, J., and H. Perlman. 2008. BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention. Oncogene 27(Suppl. 1):S168-S175.
2. Oberst, A., C. P. Dillon, R. Weinlich, L. L. McCormick, P. Fitzgerald, C. Pop, R. Hakem, G. S. Salvesen, and D. R. Green. 2011. Catalytic activity of the caspase-8-FLIP (L) complex inhibits RIPK3-dependent necrosis. Nature 471:363-367.
3. Helfer, B., B. C. Boswell, D. Finlay, A. Cipres, K. Vuori, T. Bong Kang, D. Wallach, A. Dorfleutner, J. M. Lahti, D. C. Flynn, and S. M. Frisch. 2006. Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. Cancer Res. 66:4273-4278.
4. Dohrman, A., T. Kataoka, S. Cuenin, J. Q. Russell, J. Tschopp, and R. C. Budd. 2005. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kappa B activation. J. Immunol. 174:5270-5278.
5. Rajput, A., A. Kovalenko, K. Bogdanov, S. H. Yang, T. B. Kang, J. C. Kim, J. Du, and D. Wallach. 2011. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 34:340-351.
6. Kovalenko, A., J. C. Kim, T. B. Kang, A. Rajput, K. Bogdanov, O. Dittrich-Breiholz, M. Kracht, O. Brenner, and D. Wallach. 2009. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J. Exp. Med. 206:2161-2177.
7. Hu, W. H., H. Johnson, and H. B. Shu. 2000. Activation of NF-kappaB by FADD, Casper, and caspase-8. J. Biol. Chem. 275:10838-10844.
8. Oberst, A., and D. R. Green. 2011. It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival. Nat. Rev. Mol. Cell Biol. 12:757-763.
9. Mocarski, E. S., J. W. Upton, and W. J. Kaiser. 2012. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat. Rev. Immunol. 12:79-88.
10. Feoktistova, M., P. Geserick, B. Kellert, D. P. Dimitrova, C. Langlais, M. Hupe, K. Cain, M. MacFarlane, G. Häcker, and M. Leverkus. 2011. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43:449-463.
11. Vince, J. E., W. W. Wong, I. Gentle, K. E. Lawlor, R. Allam, L. O'Reilly, K. Mason, O. Gross, S. Ma, G. Guarda, et al. 2012. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36:215-227.
12. Rönnblom, L., and V. Pascual. 2008. The innate immune system in SLE: type I interferons and dendritic cells. Lupus 17:394-399.
13. Sears, N., G. C. Sen, G. R. Stark, and S. Chattopadhyay. 2011. Caspase-8-mediated cleavage inhibits IRF-3 protein by facilitating its proteasome-mediated degradation. J. Biol. Chem. 286:33037-33044.
14. Stranges, P. B., J. Watson, C. J. Cooper, C. M. Choisy-Rossi, A. C. Stonebraker, R. A. Beighton, H. Hartig, J. P. Sundberg, S. Servick, G. Kaufmann, et al. 2007. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26:629-641.
15. Hao, Z., G. S. Duncan, J. Seagal, Y. W. Su, C. Hong, J. Haight, N. J. Chen, A. Elia, A. Wakeham, W. Y. Li, et al. 2008. Fas receptor expression in germinalcenter B cells is essential for T and B lymphocyte homeostasis. Immunity 29:615-627.
16. Hao, Z., B. Hampel, H. Yagita, and K. Rajewsky. 2004. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J. Exp. Med. 199:1355-1365.
17. Strasser, A., P. J. Jost, and S. Nagata. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30:180-192.
18. Ch'en, I. L., J. S. Tsau, J. D. Molkentin, M. Komatsu, and S. M. Hedrick. 2011. Mechanisms of necroptosis in T cells. J. Exp. Med. 208:633-641.
19. Kaiser, W. J., J. W. Upton, A. B. Long, D. Livingston-Rosanoff, L. P. Daley-Bauer, R. Hakem, T. Caspary, and E. S. Mocarski. 2011. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471:368-372.
20. Chen, M., Y. H. Wang, Y. Wang, L. Huang, H. Sandoval, Y. J. Liu, and J. Wang. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311:1160-1164.
21. Beisner, D. R., I. L. Ch'en, R. V. Kolla, A. Hoffmann, and S. M. Hedrick. 2005. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J. Immunol. 175:3469-3473.
22. Hutcheson, J., J. C. Scatizzi, A. M. Siddiqui, G. K. Haines, III, T. Wu, Q. Z. Li, L. S. Davis, C. Mohan, and H. Perlman. 2008. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28:206-217.
23. Cuda, C. M., H. Agrawal, A. V. Misharin, G. K. Haines, III, J. Hutcheson, E. Weber, J. A. Schoenfeldt, C. Mohan, R. M. Pope, and H. Perlman. 2012. Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice. Arthritis Rheum. 64:808-820.
24. Rose, S., A. Misharin, and H. Perlman. 2012. A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry A 81:343-350.
25. Labeur, M. S., B. Roters, B. Pers, A. Mehling, T. A. Luger, T. Schwarz, and S. Grabbe. 1999. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162:168-175.
26. Scatizzi, J. C., M. Mavers, J. Hutcheson, B. Young, B. Shi, R. M. Pope, E. M. Ruderman, D. S. Samways, J. A. Corbett, T. M. Egan, and H. Perlman. 2009. The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages. Eur. J. Immunol. 39:820-825.
27. Ashany, D., A. Savir, N. Bhardwaj, and K. B. Elkon. 1999. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J. Immunol. 163:5303-5311.
28. Guo, Z., M. Zhang, H. An, W. Chen, S. Liu, J. Guo, Y. Yu, and X. Cao. 2003. Fas ligation induces IL-1beta-dependent maturation and IL-1beta-independent survival of dendritic cells: different roles of ERK and NF-kappaB signaling pathways. Blood 102:4441-4447.
29. Kang, T. B., S. H. Yang, B. Toth, A. Kovalenko, and D. Wallach. 2013. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38:27-40.
30. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
31. Takahashi, N., L. Duprez, S. Grootjans, A. Cauwels, W. Nerinckx, J. B. Du Hadaway, V. Goossens, R. Roelandt, F. Van Hauwermeiren, C. Libert, et al. 2012. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 3:e437.
32. Mathis, D., and C. Benoist. 2011. Microbiota and autoimmune disease: the hosted self. Cell Host Microbe 10:297-301.
33. Gurung, P., P. K. Anand, R. K. Malireddi, L. Vande Walle, N. Van Opdenbosch, C. P. Dillon, R. Weinlich, D. R. Green, M. Lamkanfi, and T. D. Kanneganti. 2014. FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J. Immunol. 192:1835-1846.
34. Shenderov, K., N. Riteau, R. Yip, K. D. Mayer-Barber, S. Oland, S. Hieny, P. Fitzgerald, A. Oberst, C. P. Dillon, D. R. Green, et al. 2014. Cutting edge: Endoplasmic reticulum stress licenses macrophages to produce mature IL-1b in response to TLR4 stimulation through a caspase-8- and TRIF-dependent pathway. J. Immunol. 192:2029-2033.
35. Celhar, T., R. Magalhães, and A. M. Fairhurst. 2012. TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol. Res. 53:58-77.
36. Joffre, O., M. A. Nolte, R. Spörri, and C. Reis E Sousa. 2009. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 227:234-247.
37. Teichmann, L. L., M. L. Ols, M. Kashgarian, B. Reizis, D. H. Kaplan, and M. J. Shlomchik. 2010. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity 33:967-978.
38. West, A. P., A. A. Koblansky, and S. Ghosh. 2006. Recognition and signaling by toll-like receptors. Annu. Rev. Cell Dev. Biol. 22:409-437.
39. Teichmann, L. L., D. Schenten, R. Medzhitov, M. Kashgarian, and M. J. Shlomchik. 2013. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 38:528-540.
40. Jia, S. H., J. Parodo, A. Kapus, O. D. Rotstein, and J. C. Marshall. 2008. Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8. J. Biol. Chem. 283:5402-5413.
41. Lamagna, C., P. Scapini, J. A. Van Ziffle, A. L. De Franco, and C. A. Lowell. 2013. Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation. Proc. Natl. Acad. Sci. USA 110:E3311-E3320.
42. Young, J. A., T. H. He, B. Reizis, and A. Winoto. 2013. Commensal microbiota are required for systemic inflammation triggered by necrotic dendritic cells. Cell. Rep. 3:1932-1944.
43. Sriram, U., L. Varghese, H. L. Bennett, N. R. Jog, D. K. Shivers, Y. Ning, E. M. Behrens, R. Caricchio, and S. Gallucci. 2012. Myeloid dendritic cells from B6. NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset. J. Immunol. 189:80-91.
44. Chattopadhyay, S., and G. C. Sen. 2010. IRF-3 and Bax: a deadly affair. Cell Cycle 9:2479-2480.
45. Paun, A., and P. M. Pitha. 2007. The IRF family, revisited. Biochimie 89:744-753.
46. Feng, D., R. C. Stone, M. L. Eloranta, N. Sangster-Guity, G. Nordmark, S. Sigurdsson, C. Wang, G. Alm, A. C. Syvänen, L. Rönnblom, and B. J. Barnes. 2010. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum. 62:562-573.
47. Kis-Toth, K., and G. C. Tsokos. 2010. Dendritic cell function in lupus: Independent contributors or victims of aberrant immune regulation. Autoimmunity 43:121-130.
48. Monrad, S., and M. J. Kaplan. 2007. Dendritic cells and the immunopathogenesis of systemic lupus erythematosus. Immunol. Res. 37:135-145.
49. Chan, V. S., Y. J. Nie, N. Shen, S. Yan, M. Y. Mok, and C. S. Lau. 2012. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun. Rev. 11:890-897.
50. Berkun, Y., I. Verbovetski, A. Ben-Ami, D. Paran, D. Caspi, A. Krispin, U. Trahtemberg, O. Gill, Y. Naparstek, and D. Mevorach. 2008. Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus. Eur. J. Immunol. 38:2896-2904.
51. Decker, P., I. Kötter, R. Klein, B. Berner, and H. G. Rammensee. 2006. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 45:1087-1095.
52. Sang, A., Y. Yin, Y. Y. Zheng, and L. Morel. 2012. Animal models of molecular pathology systemic lupus erythematosus. Prog. Mol. Biol. Transl. Sci. 105:321-370